HHS Launches New Crackdown on Audit Failures—And New York Addiction Programs Could Face Funding Cuts
A new HHS initiative called AERO threatens funding cuts for states with unresolved audit findings. New York addiction treatment providers receiving federal dollars face heightened scrutiny.
The Department of Health and Human Services sent a clear message to state governments last week: years of unresolved audit findings will no longer be tolerated. The new initiative, called AERO—the Audit Enforcement and Risk Oversight program—threatens to withhold federal funds from states and grantees that fail to address chronic compliance failures.
For New York's addiction treatment infrastructure, which depends on hundreds of millions in federal grants annually, the announcement carries significant weight.
What AERO Actually Does
Gustav Chiarello, HHS Assistant Secretary for Financial Resources, described the problem bluntly in the May 21 announcement: "Years of audit reports documented serious vulnerabilities and failures in oversight, yet states and grantees faced little to no consequences."
The initiative employs AI-powered analytical tools to examine at least five years of audit history across all 50 states. Initial findings reveal a pattern of persistent noncompliance—some internal control issues have remained unaddressed for five years or more. Hundreds of HHS grantees have failed to submit required audits, with some delinquent by over two years.
Under AERO, HHS gains leverage to enforce compliance through several mechanisms:
- Temporarily withholding payments until recipients take corrective action
- Disallowing costs associated with noncompliance
- Suspending or terminating awards entirely
- Initiating suspension or debarment proceedings
- Withholding future federal funding for affected programs
Why New York Programs Should Pay Attention
New York's Office of Addiction Services and Supports (OASAS) administers a network of treatment providers that collectively serve tens of thousands of residents. Much of this system's funding flows through federal channels—SAMHSA block grants, State Opioid Response funding, and various HHS-administered programs.
The AERO announcement specifically warns that "states with delinquent submissions or persistent unresolved findings should expect further communication in the coming weeks." While HHS has not publicly named specific states, the department's analysis covers all 50 state audit histories.
The timing matters. New York has faced scrutiny over opioid settlement fund management in recent months, with questions raised about transparency in how counties allocate pharmaceutical lawsuit proceeds. A separate federal audit initiative targeting program integrity adds another layer of oversight pressure.
The Broader Context
AERO represents the latest in a series of Trump administration efforts to tighten federal grant oversight. The initiative cites authority under the Single Audit Act and Uniform Guidance regulations—longstanding requirements that have historically seen inconsistent enforcement.
Federal law requires any entity expending $1 million or more in federal funds annually to undergo a Single Audit examining both financial statements and program compliance. These audits check for deficiencies in areas like allowable costs, eligibility verification, and reporting timeliness.
The problem, according to HHS, has been follow-through. Despite audit findings documenting control weaknesses, previous enforcement efforts "failed to produce meaningful compliance." AERO aims to change that calculus by attaching real financial consequences to unresolved findings.
What Happens Next
HHS has signaled a two-track approach. For grantees willing to address their audit issues, the department promises partnership and support. For those who resist, the agency threatens "any and all remedies permitted under law."
The department has established a dedicated email address—AuditResolution@hhs.gov—for states and grantees seeking to engage on their audit status.
For New York treatment providers, the immediate practical impact remains unclear. The initiative just launched, and HHS has not specified how quickly enforcement actions might begin. However, the announcement's language suggests the department intends to move decisively rather than allow years of additional delay.
The Bottom Line
Federal funding supports a substantial portion of New York's addiction treatment capacity. Any disruption to that funding stream—whether through payment withholding, cost disallowance, or award termination—would reverberate through the state's treatment network.
Providers receiving HHS funding should review their own audit histories and compliance postures. The era of unchecked audit findings appears to be ending.
For questions about Single Audit requirements or to contact HHS regarding audit resolution, providers can reach the Audit Resolution Division at AuditResolution@hhs.gov.
Written by
MTNYC Editorial TeamThe MTNYC Editorial Team is a group of healthcare writers, researchers, and addiction specialists dedicated to providing accurate, compassionate, and evidence-based information about addiction treatment and recovery resources in New York State.
